David Holtzman, MD

Scientific Advisor

David Holtzman is the Andrew B. and Gretchen P. Jones Professor and the chairman of the department of neurology at the Washington University School of Medicine in St. Louis. He is also the associate director of the university’s Alzheimer’s Disease Research Center and the scientific director of the Hope Center for Neurological Disorders. Holtzman has conducted groundbreaking studies on Alzheimer’s disease and hypoxic-ischemic brain injury. In 2008, Holtzman was elected to the Institute of Medicine of the National Academy of Sciences. In addition to serving on numerous advisory committees, editorial boards and professional societies, Holtzman maintains an active role as a teacher and mentor of neurology residents as well as of postdoctoral, graduate and medical students. He holds a Doctor of Medicine from Northwestern University and completed his residency in neurology at the University of California, San Francisco. His bachelor’s degree, also from Northwestern, is in medical education.

Holtzman’s discoveries concerning the production of amyloid-beta at neuronal synapses and the identification of new ways to measure how amyloid-beta is produced and cleared from the human brain were named two of the top 50 scientific innovations in 2006 by Scientific American. His many honors include the American Academy of Neurology’s 2003 Potamkin Prize for Research on Alzheimer’s, Pick’s and Related Diseases, and a 2004 MERIT Award from the National Institute on Aging.